S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
NASDAQ:LIFE

aTyr Pharma - LIFE SEC Filings & 10K Form

$3.68
-0.02 (-0.54%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.66
$3.76
50-Day Range
$2.63
$3.72
52-Week Range
$2.60
$13.10
Volume
47,526 shs
Average Volume
124,878 shs
Market Capitalization
$103.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00

Recent aTyr Pharma SEC Filings

DateFilerForm TypeView
07/06/2022
4:02 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
3:30 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
7:04 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2022
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2022
4:14 PM
aTyr Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/28/2022
6:57 PM
aTyr Pharma (Issuer)
Zaknoen Sara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:53 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:50 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:46 PM
aTyr Pharma (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:42 PM
aTyr Pharma (Issuer)
COUGHLIN TIMOTHY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:39 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
4:07 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2022
4:00 PM
aTyr Pharma (Filer)
Form 424B5
04/14/2022
3:45 PM
aTyr Pharma (Filer)
Form 8-K/A
04/13/2022
7:09 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2021
11:31 AM
aTyr Pharma (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
09/15/2021
8:44 PM
aTyr Pharma (Filer)
Form S-3MEF
09/13/2021
7:30 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2021
11:16 PM
aTyr Pharma (Filer)
Form EFFECT
07/12/2021
11:07 AM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
05/25/2021
8:06 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:05 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:04 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:03 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:02 PM
aTyr Pharma (Issuer)
Zaknoen Sara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:00 PM
aTyr Pharma (Issuer)
Zaknoen Sara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/25/2021
7:04 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2021
7:55 AM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
7:52 AM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
3:08 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2021
7:13 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
7:11 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
7:08 PM
aTyr Pharma (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
7:06 PM
aTyr Pharma (Issuer)
COUGHLIN TIMOTHY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
7:02 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2021
12:05 PM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
04/09/2021
1:14 PM
aTyr Pharma (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
03/24/2021
8:26 AM
aTyr Pharma (Filer)
Form 424B5
03/23/2021
8:23 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2021
7:09 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2021
3:49 PM
aTyr Pharma (Filer)
Form PRE 14A
03/09/2021
3:23 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4/A
02/17/2021
5:10 AM
Aspire Capital Fund, LLC (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/16/2021
10:21 AM
Alyeska Investment Group, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/12/2021
12:17 PM
aTyr Pharma (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
02/09/2021
8:15 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
8:12 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:16 PM
aTyr Pharma (Filer)
Form 424B5
02/08/2021
7:18 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:13 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:08 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
9:15 AM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/25/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
8:01 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:20 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
11/13/2020
4:24 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/02/2020
4:11 PM
aTyr Pharma (Filer)
Form 424B3
09/28/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
09/18/2020
3:26 PM
aTyr Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/14/2020
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
8:47 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
8:09 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:40 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2020
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2020
3:27 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
7:26 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
7:22 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
7:17 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
7:13 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:19 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
3:16 PM
aTyr Pharma (Filer)
Form 424B5
05/12/2020
4:06 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
4:14 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
4:08 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
7:35 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
3:16 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2020
4:13 PM
aTyr Pharma (Filer)
Form PRE 14A
02/28/2020
4:16 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
1:46 PM
Altium Capital Management LP (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/12/2020
1:41 PM
aTyr Pharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/11/2020
12:27 PM
aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/11/2020
10:58 AM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:37 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:34 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:30 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
4:31 PM
aTyr Pharma (Filer)
Form 424B4
02/05/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
02/05/2020
8:53 PM
aTyr Pharma (Filer)
Form POS EX
02/05/2020
8:48 PM
aTyr Pharma (Filer)
Form S-1MEF
02/03/2020
7:01 AM
aTyr Pharma (Filer)
Form S-1/A
01/27/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1/A
01/17/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/14/2020
4:28 PM
Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G/A
01/06/2020
8:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
7:10 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page (NASDAQ:LIFE) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.